Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kirstein-Smardzewska KJ"'
Autor:
Desalegn AA; Division of Climate and Environmental Health, Norwegian Institute of Public Health, 0456, Oslo, Norway; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., van der Ent W; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, Oslo, Norway., Lenters V; Division of Climate and Environmental Health, Norwegian Institute of Public Health, 0456, Oslo, Norway., Iszatt N; Division of Climate and Environmental Health, Norwegian Institute of Public Health, 0456, Oslo, Norway., Stigum H; Department of Non-Communicable Diseases, Norwegian Institute of Public Health, Oslo, Norway., Lyche JL; Department of Paraclinical Sciences, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, P.O. Box 369 Sentrum, NO-0102, Oslo, Norway., Berg V; Department of Paraclinical Sciences, Faculty of Veterinary Medicine, Norwegian University of Life Sciences, P.O. Box 369 Sentrum, NO-0102, Oslo, Norway., Kirstein-Smardzewska KJ; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, Oslo, Norway., Esguerra CV; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, Oslo, Norway; Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Eggesbø M; Division of Climate and Environmental Health, Norwegian Institute of Public Health, 0456, Oslo, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway; Department of Occupational and Environmental Medicine, University Hospital of North Norway, Tromsø, Norway. Electronic address: merete.eggesbo@ntnu.no.
Publikováno v:
Environment international [Environ Int] 2023 Nov; Vol. 181, pp. 108271. Date of Electronic Publication: 2023 Oct 18.
Autor:
Silvennoinen K; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, Box 29, Queen Square, London, WC1N 3BG, UK.; Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks, SL9 0RJ, UK., Gawel K; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, 0349, Oslo, Norway.; Department of Experimental and Clinical Pharmacology, Medical University of Lublin, 20-090, Lublin, Poland., Tsortouktzidis D; Institute of Neuropathology, Medical Faculty, University of Bonn, Section for Translational Epilepsy Research, 53127, Bonn, Germany.; Department of Epileptology, Medical Faculty, University of Bonn, 53127, Bonn, Germany., Pitsch J; Institute of Neuropathology, Medical Faculty, University of Bonn, Section for Translational Epilepsy Research, 53127, Bonn, Germany.; Department of Epileptology, Medical Faculty, University of Bonn, 53127, Bonn, Germany., Alhusaini S; Department of Molecular and Cellular Therapeutics, The Royal College of Surgeons in Ireland, Dublin 2, Ireland.; Department of Neurology, Yale University School of Medicine, New Haven, CT, 06520, USA., van Loo KMJ; Institute of Neuropathology, Medical Faculty, University of Bonn, Section for Translational Epilepsy Research, 53127, Bonn, Germany.; Department of Epileptology and Neurology, RWTH Aachen University, 52074, Aachen, Germany., Picardo R; Department of Neuropathology, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK., Michalak Z; Department of Neuropathology, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK., Pagni S; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, Box 29, Queen Square, London, WC1N 3BG, UK.; Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks, SL9 0RJ, UK., Martins Custodio H; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, Box 29, Queen Square, London, WC1N 3BG, UK.; Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks, SL9 0RJ, UK., Mills J; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, Box 29, Queen Square, London, WC1N 3BG, UK.; Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks, SL9 0RJ, UK., Whelan CD; Department of Molecular and Cellular Therapeutics, The Royal College of Surgeons in Ireland, Dublin 2, Ireland.; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, Los Angele, CA, 90292, USA., de Zubicaray GI; School of Psychology, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, 4059, Australia., McMahon KL; School of Clinical Sciences, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, 4029, Australia., van der Ent W; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, 0349, Oslo, Norway., Kirstein-Smardzewska KJ; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, 0349, Oslo, Norway., Tiraboschi E; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, 0349, Oslo, Norway., Mudge JM; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK., Frankish A; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK., Thom M; Department of Neuropathology, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK., Wright MJ; Queensland Brain Institute, University of Queensland, St Lucia, 4072 QLD, Australia., Thompson PM; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, Los Angele, CA, 90292, USA., Schoch S; Institute of Neuropathology, Medical Faculty, University of Bonn, Section for Translational Epilepsy Research, 53127, Bonn, Germany.; Department of Epileptology, Medical Faculty, University of Bonn, 53127, Bonn, Germany., Becker AJ; Institute of Neuropathology, Medical Faculty, University of Bonn, Section for Translational Epilepsy Research, 53127, Bonn, Germany., Esguerra CV; Chemical Neuroscience Group, Centre for Molecular Medicine Norway (NCMM), Faculty of Medicine, University of Oslo, 0349, Oslo, Norway., Sisodiya SM; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, Box 29, Queen Square, London, WC1N 3BG, UK. s.sisodiya@ucl.ac.uk.; Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks, SL9 0RJ, UK. s.sisodiya@ucl.ac.uk.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2022 Jul; Vol. 144 (1), pp. 107-127. Date of Electronic Publication: 2022 May 12.
Autor:
Gawel K; Chemical Neuroscience Group, Centre for Molecular Medicine Norway, Faculty of Medicine, University of Oslo, Gaustadalléen 21, Forskningsparken, 0349, Oslo, Norway.; Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego St. 8b, 20-090, Lublin, Poland., Turski WA; Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego St. 8b, 20-090, Lublin, Poland., van der Ent W; Chemical Neuroscience Group, Centre for Molecular Medicine Norway, Faculty of Medicine, University of Oslo, Gaustadalléen 21, Forskningsparken, 0349, Oslo, Norway., Mathai BJ; Faculty of Medicine, Institute of Basic Medical Sciences and Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, University of Oslo, 1112 Blindern, 0317, Oslo, Norway., Kirstein-Smardzewska KJ; Chemical Neuroscience Group, Centre for Molecular Medicine Norway, Faculty of Medicine, University of Oslo, Gaustadalléen 21, Forskningsparken, 0349, Oslo, Norway., Simonsen A; Faculty of Medicine, Institute of Basic Medical Sciences and Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, University of Oslo, 1112 Blindern, 0317, Oslo, Norway., Esguerra CV; Chemical Neuroscience Group, Centre for Molecular Medicine Norway, Faculty of Medicine, University of Oslo, Gaustadalléen 21, Forskningsparken, 0349, Oslo, Norway. c.v.esguerra@ncmm.uio.no.; School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Sem Sælandsvei 24, 0371, Oslo, Norway. c.v.esguerra@ncmm.uio.no.
Publikováno v:
Molecular neurobiology [Mol Neurobiol] 2020 Apr; Vol. 57 (4), pp. 1904-1916. Date of Electronic Publication: 2019 Dec 26.